Lack of Aberrant Methylation in an Adjacent Area of Left-Sided Colorectal Cancer

키워드

참고문헌 (39)

1. Slaughter DP, "Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin", Cancer, 6, pp.963~968 (1953)
2. Braakhuis BJ, "A genetic explanation of Slaughter’s concept of field cancerization:evidence and clinical implications", Cancer Res, 63, pp.1727~1730 (2003)
3. Grady WM, "Epigenetic events in the colorectum and in colon cancer", Biochem Soc Trans, 33(Pt 4), pp.684~688 (2005)
4. Luo Y, "Field cancerization in the colon: a role for aberrant DNA methylation?", Gastroenterol Rep (Oxf), 2, pp.16~20 (2014)
5. Joo Mi Yi, "Epigenetic Alterations in Inflammatory Bowel Disease and Cancer", Intestinal research, 13(2), pp.112~121 (2015), 대한장연구학회
6. Baba Y, "Epigenetic field cancerization in gastrointestinal cancers", Cancer Lett, 375, pp.360~366 (2016)
7. Baylin SB, "DNA hypermethylation in tumorigenesis:epigenetics joins genetics", Trends Genet, 16, pp.168~174 (2000)
8. Feinberg AP, "The epigenetic progenitor origin of human cancer", Nat Rev Genet, 7, pp.21~33 (2006)
9. Rashid A, "CpG island methylation in colorectal adenomas", Am J Pathol, 159, pp.1129~1135 (2001)
10. Li H, "SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers", Proc Natl Acad Sci U S A, 100, pp.8412~8417 (2003)
11. Kondo Y, "Epigenetic changes in colorectal cancer", Cancer Metastasis Rev, 23, pp.29~39 (2004)
12. Shen L, "MGMT promoter methylation and field defect in sporadic colorectal cancer", J Natl Cancer Inst, 97, pp.1330~1338 (2005)
13. Esteller M, "Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes", Eur J Cancer, 36, pp.2294~2300 (2000)
14. Issa JP, "CpG island methylator phenotype in cancer", Nat Rev Cancer, 4, pp.988~993 (2004)
15. Issa JP, "Accelerated age-related CpG island methylation in ulcerative colitis", Cancer Res, 61, pp.3573~3577 (2001)
16. Clark SJ, "High sensitivity mapping of methylated cytosines", Nucleic Acids Res, 22, pp.2990~2997 (1994)
17. Colella S, "Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites", Biotechniques, 35, pp.146~150 (2003)
18. Estécio MR, "LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability", PLoS One, 2, pp.e399~ (2007)
19. Ogino S, "Sensitive sequencing method for KRAS mutation detection by pyrosequencing", J Mol Diagn, 7, pp.413~421 (2005)
20. Shen L, "Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer", Proc Natl Acad Sci U S A, 104, pp.18654~18659 (2007)
21. Estécio MR, "High-throughput methylation profiling by MCA coupled to CpG island microarray", Genome Res, 17, pp.1529~1536 (2007)
22. Chung W, "Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling", PLoS One, 3, pp.e2079~ (2008)
23. Yamashita S, "Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2’-deoxycytidine treatment and oligonucleotide microarray", Cancer Sci, 97, pp.64~71 (2006)
24. Hasegawa S, "Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes", Cancer Res, 62, pp.7012~7017 (2002)
25. Deng D, "Hypermethylation of metallothionein-3 CpG island in gastric carcinoma", Carcinogenesis, 24, pp.25~29 (2003)
26. Mikata R, "Analysis of genes upregulated by the demethylating agent 5-aza-2’-deoxycytidine in gastric cancer cell lines", Int J Cancer, 119, pp.1616~1622 (2006)
27. Chung SK, "Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses", Gastroenterology, 132, pp.2459~2477 (2007)
28. Ebert MP, "Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas", Gastroenterology, 131, pp.1418~1430 (2006)
29. Watanabe Y, "PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer", Clin Cancer Res, 13, pp.4786~4794 (2007)
30. Issa JP, "Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon", Nat Genet, 7, pp.536~540 (1994)
31. Goel A, "The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer", Gastroenterology, 132, pp.127~138 (2007)
32. Clement Richard Boland, "Promoter Methylation in the Genesis of Gastrointestinal Cancer", Yonsei Medical Journal, 50(3), pp.309~321 (2009), 연세대학교의과대학
33. Zou H, "Highly methylated genes in colorectal neoplasia: implications for screening", Cancer Epidemiol Biomarkers Prev, 16, pp.2686~2696 (2007)
34. Chan AO, "CpG island methylation in aberrant crypt foci of the colorectum", Am J Pathol, 160, pp.1823~1830 (2002)
35. Jothy S, "Field effect of human colon carcinoma on normal mucosa: relevance of carcinoembryonic antigen expression", Tumour Biol, 17, pp.58~64 (1996)
36. Nguyen C, "Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells", J Natl Cancer Inst, 93, pp.1465~1472 (2001)
37. Ushijima T, "DNA methylation as a marker for the past and future", J Gastroenterol, 41, pp.401~407 (2006)
38. Ehrlich M, "DNA methylation in cancer: too much, but also too little", Oncogene, 21, pp.5400~5413 (2002)
39. Eads CA, "MethyLight: a high-throughput assay to measure DNA methylation", Nucleic Acids Res, 28, pp.E32~ (2000)

관련 논문AI추천